Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: TAC T-cells for the Treatment of HER2-positive Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating TAC T-cells for HER2-positive solid tumors, including HER2-positive gastric cancer and metastatic HER2-positive g…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) [Phase 2]
Phase 2 neoadjuvant trial PANDA investigates a four-drug regimen (capecitabine, oxaliplatin, docetaxel, and atezolizumab) for resectable gas…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer [NA]
A clinical trial comparing robotic versus laparoscopic radical surgery for locally advanced gastric cancer is currently recruiting in China.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: HTL0039732 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
HTL0039732 is being evaluated in a Phase 1/2 study for multiple advanced solid tumours and is currently recruiting.
-
FDA approval · 2025-06-06FDA Approved: VYLOY — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for VYLOY (zolbetuximab) from Astellas Pharma US, expanding/updating its labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma
A completed neoadjuvant trial comparing nivolumab plus SOX versus nivolumab plus FLOT in HER2-negative gastric and gastroesophageal junction…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer
This clinical trial evaluated conversion surgery after targeted therapy or immunotherapy for stage IV gastric cancer; the study status is co…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Early Detection and Post-operative Monitoring of Gastric Cancer
The document announces a recruiting clinical trial focused on early detection and post-operative monitoring for gastric cancer, sponsored by…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Nasal Mask Kit in Gastrointestinal Endoscopy [NA]
A completed clinical trial evaluating a nasal mask kit used during gastrointestinal endoscopy, with indications including gastric cancer, co…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer [Phase 2]
Phase 2 trial update for Ivonescimab (AK112) plus paclitaxel as second-line therapy in advanced gastric/gastroesophageal junction cancer; th…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery [Phase 1, Phase 2]
This update covers a Phase 1/2 trial of olaparib plus ramucirumab in patients with metastatic or locally recurrent gastric or gastroesophage…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
Exploratory clinical trial evaluating a precision therapy approach guided by PTC drug sensitivity testing in patients with advanced cancers …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy (Age ≥ 18 Years, Informed Consent), Between Total Inspection Time Versus Withdrawal Time, for the Identification of Malignant Lesions [NA]
A recruiting clinical study in adults evaluating whether total inspection time or withdrawal time during diagnostic or surveillance upper ga…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
A clinical trial evaluating tongue imaging as a screening and diagnostic tool for gastric cancer and investigating the mechanisms of tongue …
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of electroacupuncture, paclitaxel protein-bound, and a PD-1 antibody as second-line ther…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer
A clinical trial update notes ongoing recruitment for a study examining the relationship between psychological distress and immune checkpoin…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors [Phase 1]
Phase 1 study evaluating intra-tumoral injections of vvDD-hIL2-2-RG-1 for metastatic gastric, esophageal, liver, colorectal, and peritoneal …
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer [Phase 2]
Phase 2 clinical study evaluating the efficacy and safety of paclitaxel polymeric micelles for injection in patients with taxane-resistant p…
-
CLINICAL_TRIALS research · 2025-06-02Clinical Trial Update: Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma [Phase 2, Phase 3]
This clinical trial update outlines a Phase 2/Phase 3 study evaluating the timing of minimally invasive local treatment following first-line…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: JSKN003 Combined Treatment of HER2-positive Gastric Cancer [Phase 2]
A Phase 2 study of JSKN003 combined therapy for HER2-positive gastric cancer is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method [NA]
This clinical trial compares OGT-assisted overlap esophagojejunostomy to the traditional overlap method for gastric cancer and is currently …
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore [Phase 2]
Phase 2 clinical trial assessing first-line treatment with lenvatinib plus tislelizumab and CapeOX for advanced gastric/gastroesophageal jun…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies [NA]
A clinical trial update on the impact of intelligent nutrition management on clinical outcomes in chemotherapy patients with gastric cancer …
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
This clinical trial aims to predict response to hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric and colon cancers with peritone…